Trial intelligence / Profile preview

Levetiracetam vs Phenytoin in Pediatric Status Epilepticus

NCT04176887Phase 4Unknown

Sponsor
Tanta University
Start
Jan 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by Tanta University. Primary endpoint: Cessation of convulsion at 30 minutes. Status: unknown.

02

Drugs

levetiracetam
03

Conditions

status epilepticus (SE)

Beyond the preview

Go deeper on NCT04176887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04176887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call